In vivo assessment of cancerous tumors using boron doped diamond microelectrode

49Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The in vitro and in vivo electrochemical detection of the reduced form of glutathione (L-γ-glutamyl-L-cysteinyl-glycine, GSH) using boron doped diamond (BDD) microelectrode for potential application in the assessment of cancerous tumors is presented. Accurate calibration curve for the determination of GSH could be obtained by the in vitro electrochemical measurements. Additionally, it was shown that it was possible to separate the detection of GSH from the oxidized form of glutathione (GSSG) using chronoamperometry measurements. In vivo GSH detection measurements have been performed in human cancer cells inoculated in immunodeficient mice. These measurements have shown that the difference of GSH level between cancerous and normal tissues can be detected. Moreover, GSH detection measurements carried out before and after X-ray irradiation have proved that it is possible to assess in vivo the decrease in GSH concentration in the tumor after a specific treatment.

Cite

CITATION STYLE

APA

Fierro, S., Yoshikawa, M., Nagano, O., Yoshimi, K., Saya, H., & Einaga, Y. (2012). In vivo assessment of cancerous tumors using boron doped diamond microelectrode. Scientific Reports, 2. https://doi.org/10.1038/srep00901

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free